Iovance Biotherapeutics, Inc. (IOVA)
Market Closed
15 Oct, 08:00 PM
$
14. 72
+0.51
+3.589%
Pre Market
$
+0.03 +0.2038% 14. 75
6.67B Market Cap
- P/E Ratio
- Div Yield
11.49M Volume
-1.87 Eps
$ 14.21
Previous Close 
Want to track IOVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Iovance Biotherapeutics, Inc. (IOVA) Statistics
Valuation metrics
Market Cap 6.67B
Enterprise value 6.46B
Trailing P/E (ttm) -20.89
Forward P/E -12.88
PEG ratio -0.35
Price/Sales (ttm) 20.09
Price/Book (mrq) 8.94
Enterprise Value/Revenue 19.89
Enterprise Value/EBITDA -25.98
Overview
Shares outstanding 438.11M
Float 387.98M
Shares short 114.71M
% Held by insiders 0%
% Held by institutions 0.67%
Average volume (10 days) 16.78M
Average volume (90 days) 20.26M
Price summary
52-Week low 1.76
52-Week high 15.3
Beta 0.69
50-Day moving average 12.37
200-Day moving average 5.32
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:100
Last split Date 26 Sep 2013
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.89%
Operating margin -0.93%
Operational effectiveness
Return on assets -0.32%
Return on equity -0.41%
Income Statement
Revenue (ttm) 285.61M
Revenue per share (ttm) 0.72
Quarterly revenue growth (yoy) 0.45%
Gross profit (ttm) 112.64M
EBITDA -321.62M
Net income to common (ttm) -353.86M
Diluted EPS (ttm) -0.64
Quarterly earnings growth (yoy) 0.45%
Balance Sheet
Total cash (mrq) 313.44M
Total cash per share (mrq) 0.66
Total debt (mrq) 47.78M
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 4.35%
Book value per share (mrq) 1.63
Cash Flow
Cash flow statement -270.79M
Levered free cash flow (LFCF) -149.07M
2026 © Marketlog. All Rights Reserved.
